Brief: Alzchem Group AG - €120 Million Investment In New Automated Creatine Facility
Dec 4 (Reuters) - Alzchem Group AG ACT1.DE: ALZCHEM GROUP AG - €120 MILLION INVESTMENT IN NEW AUTOMATED CREATINE FACILITY ALZCHEM GROUP AG - COMMISSIONING PLANNED FROM SECOND HALF OF 2027 ALZCHEM GROUP AG - ALZCHEM SEES THIS INVESTMENT AS OFFERING ADDITIONAL ANNUAL SALES POTENTIAL IN LOW TRIPLE-DIGIT MILLION EURO RANGE Source text: ID:nEQbJxh8Ja Further company coverage: ACT1.DE (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))
Recent news on AlzChem AG
See all newsGermany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Brief: Alzchem Confirms Full-year 2026 Outlook
Brief: Alzchem Selects Bushy Park, South Carolina For Nitroguanidine Production Facility
Germany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group